REQUEST A DEMO
Total
USD $0.00
Search more companies

Labcuenca By Genomedica S.A.S. (Ecuador)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Labcuenca By Genomedica S.A.S. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Labcuenca By Genomedica S.A.S. is an enterprise in Ecuador, with the main office in Cuenca. The enterprise operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on April 16, 2024. The total number of employees is currently 2 (2024). From the latest financial highlights, Labcuenca By Genomedica S.A.S. reported a net sales revenue increase of 359.01% in 2025. Its’ total assets recorded a growth of 23.41%. The net profit margin of Labcuenca By Genomedica S.A.S. decreased by 5.05% in 2025.

Headquarters
Calle Daniel Cordova, 1-111
Cuenca; Azuay;

Contact Details: Purchase the Labcuenca By Genomedica S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Labcuenca By Genomedica S.A.S. report to view the information.
Registered Capital:
Purchase the Labcuenca By Genomedica S.A.S. report to view the information.
Financial Auditors:
Purchase the Labcuenca By Genomedica S.A.S. report to view the information.
Incorporation Date:
April 16, 2024
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Labcuenca By Genomedica S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
359.01%
Total Operating Revenue
359.01%
Operating Profit
10.3%
EBITDA
10.3%
Net Profit/Loss for the Period
5.4%
Total Assets
23.41%
Total Equity
44.06%
Operating Profit Margin
-7.41%
Net Profit Margin
-5.05%
Return on Equity (ROE)
-11.22%
Quick Ratio
-0.08%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?